American Journal of Ophthalmology
Volume 130, Issue 3 , Pages 274-279, September 2000

Factors associated with long-term progression or stability in primary open-angle glaucoma

  • William C Stewart, MD

      Affiliations

    • Pharmaceutical Research Corporation (Dr Stewart, Ms Holmes, Leech, and Cantrell), Charleston, South Carolina, USA
    • Department of Ophthalmology at the University of South Carolina (Dr Stewart), Columbia, South Carolina, USA
    • Corresponding Author InformationReprint requests to William C. Stewart, MD, Pharmaceutical Research Corporation, 1639 Tatum St, Charleston, SC 29412-2464
  • ,
  • Allan E Kolker, MD

      Affiliations

    • The Glaucoma Institute (Dr Kolker), St. Louis, Missouri, USA
  • ,
  • Elizabeth D Sharpe, MD

      Affiliations

    • Ophthalmology Consultants (Dr Sharpe), Charleston, South Carolina, USA
  • ,
  • Douglas G Day, MD

      Affiliations

    • Omni Eye Services (Dr Day), Atlanta, Georgia, USA
  • ,
  • Keri T Holmes, BS

      Affiliations

    • Pharmaceutical Research Corporation (Dr Stewart, Ms Holmes, Leech, and Cantrell), Charleston, South Carolina, USA
  • ,
  • Jessica N Leech, BS

      Affiliations

    • Pharmaceutical Research Corporation (Dr Stewart, Ms Holmes, Leech, and Cantrell), Charleston, South Carolina, USA
  • ,
  • Mark Johnson, BS

      Affiliations

    • Atlanta Research Company (Mr Johnson), Atlanta, Georgia, USA
  • ,
  • Jennifer B Cantrell, BS

      Affiliations

    • Pharmaceutical Research Corporation (Dr Stewart, Ms Holmes, Leech, and Cantrell), Charleston, South Carolina, USA

Accepted 1 March 2000.

Abstract 

PURPOSE: To evaluate long-term risk factors for progression or stability in patients with primary open-angle glaucoma.

METHOD: We retrospectively included consecutively reviewed patients who had primary open-angle glaucoma for at least 5 years in this multicenter trial. Historical and clinical factors in these patients were evaluated for their association with stability or progression of the glaucoma.

RESULTS: We included 218 patients in this study; of these, 34 progressed over an average length of follow-up of 45.5 ± 30.0 months, and 184 were stable over an average of 72.8 ± 18.3 months. The mean intraocular pressure over the follow-up period for the progressed group was 19.5 ± 3.8 mm Hg and for the stable group 17.2 ± 3.1 mm Hg (P = .001). The average standard deviation of individual intraocular pressures was greater in the progressed group (5.1 mm Hg) than the stable group (3.9 mm Hg, P = .012). Baseline characteristics indicating a greater potential to progress were a larger cup-to-disk ratio (P < .001), a greater number of medications (P = .02), older age (P .007), and worse visual acuity (P = .003). However, no difference was observed in pressure levels that prevented progression in these subpopulations compared with the total sample size.

CONCLUSIONS: This study suggests that lowering the intraocular pressure is important in the treatment of primary open-angle glaucoma to help prevent long-term progression. Lowering the pressure, however, is not uniformly effective in preventing progression. Additionally, risk factors for progression do not further help identify pressure levels that prevent worsening of glaucoma.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was sponsored by an unrestricted grant from Pharmacia Inc.

PII: S0002-9394(00)00487-6

American Journal of Ophthalmology
Volume 130, Issue 3 , Pages 274-279, September 2000